Ki67 is a better marker than PRAME in risk stratification of BAP1-positive and BAP1-loss uveal melanomas. Donizy P, Spytek M, Krzyzinski M, Kotowski K, et al. Br J Ophthalmol 2024;108:1005-1010.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Donizy P, Spytek M, Krzyzinski M, Kotowski K, et al. Ki67 is a better marker than PRAME in risk stratification of BAP1-positive and BAP1-loss uveal melanomas. Br J Ophthalmol 2024;108:1005-1010.
PMID: 37734766